Literature DB >> 29904177

Phenotypic spectrum of Au-Kline syndrome: a report of six new cases and review of the literature.

P Y Billie Au1,2, Caitlin Goedhart3, Marcia Ferguson4, Jeroen Breckpot5, Koenraad Devriendt5, Klaas Wierenga6, Elizabeth Fanning6, Dorothy K Grange7, Gail E Graham8, Carolina Galarreta9, Marilyn C Jones9, Usha Kini10, Helen Stewart10, Jillian S Parboosingh11,3, Antonie D Kline4, A Micheil Innes11,3.   

Abstract

Au-Kline syndrome (AKS, OMIM 616580) is a multiple malformation syndrome, first reported in 2015, associated with intellectual disability. AKS has been associated with de novo loss-of-function variants in HNRNPK (heterogeneous ribonucleoprotein K), and to date, only four of these patients have been described in the literature. Recently, an additional patient with a missense variant in HNRNPK was also reported. These patients have striking facial dysmorphic features, including long palpebral fissures, ptosis, deeply grooved tongue, broad nose, and down-turned mouth. Patients frequently also have skeletal and connective tissue anomalies, craniosynostosis, congenital heart malformations, and renal anomalies. In this report, we describe six new patients and review the clinical information on all reported AKS patients, further delineating the phenotype of AKS. There are now a total of 9 patients with de novo loss-of-function variants in HNRNPK, one individual with a de novo missense variant in addition to 3 patients with de novo deletions of 9q21.32 that encompass HNRNPK. While there is considerable overlap between AKS and Kabuki syndrome (KS), these additional patients demonstrate that AKS does have a distinct facial gestalt and phenotype that can be differentiated from KS. This growing AKS patient cohort also informs an emerging approach to management and health surveillance for these patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29904177      PMCID: PMC6117294          DOI: 10.1038/s41431-018-0187-2

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  12 in total

1.  Del (9q) AML: clinical and cytological characteristics and prognostic implications.

Authors:  Andrew Peniket; James Wainscoat; Lucy Side; Sarah Daly; Rajko Kusec; Georgina Buck; Keith Wheatley; Helen Walker; Steve Chatters; Christine Harrison; Jacqueline Boultwood; Anthony Goldstone; Alan Burnett
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

2.  GeneMatcher aids in the identification of a new malformation syndrome with intellectual disability, unique facial dysmorphisms, and skeletal and connective tissue abnormalities caused by de novo variants in HNRNPK.

Authors:  P Y Billie Au; Jing You; A Micheil Innes; Antonie D Kline; Oana Caluseriu; Jeremy Schwartzentruber; Jacek Majewski; Francois P Bernier; Marcia Ferguson; David Valle; Jillian S Parboosingh; Nara Sobreira
Journal:  Hum Mutat       Date:  2015-08-06       Impact factor: 4.878

3.  Deletions of 9q21.3 including NTRK2 are associated with severe phenotype.

Authors:  Miroslava Hancarova; Alena Puchmajerova; Jana Drabova; Eliska Karaskova; Marketa Vlckova; Zdenek Sedlacek
Journal:  Am J Med Genet A       Date:  2014-10-27       Impact factor: 2.802

4.  Craniosynostosis in Kabuki syndrome.

Authors:  Juan F Martínez-Lage; Matías Felipe-Murcia; Encarna Guillén Navarro; María-José Almagro; Antonio López López-Guerrero; Miguel A Pérez-Espejo
Journal:  J Neurosurg Pediatr       Date:  2010-08       Impact factor: 2.375

5.  Novel interstitial 2.6 Mb deletion on 9q21 associated with multiple congenital anomalies.

Authors:  Heather H Pua; Swetha Krishnamurthi; Jessica Farrell; Marta Margeta; Philip C Ursell; Martin Powers; Anne M Slavotinek; Linda J B Jeng
Journal:  Am J Med Genet A       Date:  2014-01       Impact factor: 2.802

6.  On the significance of craniosynostosis in a case of Kabuki syndrome with a concomitant KMT2D mutation and 3.2 Mbp de novo 10q22.3q23.1 deletion.

Authors:  Alexandra Topa; Lena Samuelsson; Lovisa Lovmar; Göran Stenman; Lars Kölby
Journal:  Am J Med Genet A       Date:  2017-06-07       Impact factor: 2.802

7.  Clinical spectrum of Kabuki-like syndrome caused by HNRNPK haploinsufficiency.

Authors:  Maria Lisa Dentici; Sabina Barresi; Marcello Niceta; Francesca Pantaleoni; Simone Pizzi; Bruno Dallapiccola; Marco Tartaglia; Maria Cristina Digilio
Journal:  Clin Genet       Date:  2017-04-25       Impact factor: 4.438

8.  hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies.

Authors:  Miguel Gallardo; Hun Ju Lee; Xiaorui Zhang; Carlos Bueso-Ramos; Laura R Pageon; Mark McArthur; Asha Multani; Aziz Nazha; Taghi Manshouri; Jan Parker-Thornburg; Inmaculada Rapado; Alfonso Quintas-Cardama; Steven M Kornblau; Joaquin Martinez-Lopez; Sean M Post
Journal:  Cancer Cell       Date:  2015-09-24       Impact factor: 31.743

Review 9.  Aberrant hnRNP K expression: All roads lead to cancer.

Authors:  Miguel Gallardo; Marisa J Hornbaker; Xiaorui Zhang; Peter Hu; Carlos Bueso-Ramos; Sean M Post
Journal:  Cell Cycle       Date:  2016-06-17       Impact factor: 4.534

10.  A de novo frameshift in HNRNPK causing a Kabuki-like syndrome with nodular heterotopia.

Authors:  L Lange; A T Pagnamenta; S Lise; S Clasper; H Stewart; E S Akha; G Quaghebeur; S J L Knight; D A Keays; J C Taylor; U Kini
Journal:  Clin Genet       Date:  2016-04-01       Impact factor: 4.438

View more
  8 in total

1.  RNA-binding motifs of hnRNP K are critical for induction of antibody diversification by activation-induced cytidine deaminase.

Authors:  Ziwei Yin; Maki Kobayashi; Wenjun Hu; Koichi Higashi; Nasim A Begum; Ken Kurokawa; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-08       Impact factor: 11.205

2.  Deletion of Hnrnpk Gene Causes Infertility in Male Mice by Disrupting Spermatogenesis.

Authors:  Haixia Xu; Jiahua Guo; Wei Wu; Qiu Han; Yueru Huang; Yaling Wang; Cencen Li; Xiaofang Cheng; Pengpeng Zhang; Yongjie Xu
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

Review 3.  Connections between 3' end processing and DNA damage response: Ten years later.

Authors:  Michael Robert Murphy; Frida Esther Kleiman
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-10-28       Impact factor: 9.957

4.  Diagnostic utility of integrated analysis of exome and transcriptome: Successful diagnosis of Au-Kline syndrome in a patient with submucous cleft palate, scaphocephaly, and intellectual disabilities.

Authors:  Mamiko Yamada; Yuichi Shiraishi; Tomoko Uehara; Hisato Suzuki; Toshiki Takenouchi; Chihiro Abe-Hatano; Kenji Kurosawa; Kenjiro Kosaki
Journal:  Mol Genet Genomic Med       Date:  2020-06-26       Impact factor: 2.183

5.  Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders.

Authors:  Madelyn A Gillentine; Tianyun Wang; Kendra Hoekzema; Jill Rosenfeld; Pengfei Liu; Hui Guo; Chang N Kim; Bert B A De Vries; Lisenka E L M Vissers; Magnus Nordenskjold; Malin Kvarnung; Anna Lindstrand; Ann Nordgren; Jozef Gecz; Maria Iascone; Anna Cereda; Agnese Scatigno; Silvia Maitz; Ginevra Zanni; Enrico Bertini; Christiane Zweier; Sarah Schuhmann; Antje Wiesener; Micah Pepper; Heena Panjwani; Erin Torti; Farida Abid; Irina Anselm; Siddharth Srivastava; Paldeep Atwal; Carlos A Bacino; Gifty Bhat; Katherine Cobian; Lynne M Bird; Jennifer Friedman; Meredith S Wright; Bert Callewaert; Florence Petit; Sophie Mathieu; Alexandra Afenjar; Celenie K Christensen; Kerry M White; Orly Elpeleg; Itai Berger; Edward J Espineli; Christina Fagerberg; Charlotte Brasch-Andersen; Lars Kjærsgaard Hansen; Timothy Feyma; Susan Hughes; Isabelle Thiffault; Bonnie Sullivan; Shuang Yan; Kory Keller; Boris Keren; Cyril Mignot; Frank Kooy; Marije Meuwissen; Alice Basinger; Mary Kukolich; Meredith Philips; Lucia Ortega; Margaret Drummond-Borg; Mathilde Lauridsen; Kristina Sorensen; Anna Lehman; Elena Lopez-Rangel; Paul Levy; Davor Lessel; Timothy Lotze; Suneeta Madan-Khetarpal; Jessica Sebastian; Jodie Vento; Divya Vats; L Manace Benman; Shane Mckee; Ghayda M Mirzaa; Candace Muss; John Pappas; Hilde Peeters; Corrado Romano; Maurizio Elia; Ornella Galesi; Marleen E H Simon; Koen L I van Gassen; Kara Simpson; Robert Stratton; Sabeen Syed; Julien Thevenon; Irene Valenzuela Palafoll; Antonio Vitobello; Marie Bournez; Laurence Faivre; Kun Xia; Rachel K Earl; Tomasz Nowakowski; Raphael A Bernier; Evan E Eichler
Journal:  Genome Med       Date:  2021-04-19       Impact factor: 11.117

6.  Case Report: Exome and RNA Sequencing Identify a Novel de novo Missense Variant in HNRNPK in a Chinese Patient With Au-Kline Syndrome.

Authors:  Xin Pan; Sihan Liu; Li Liu; Xu Zhang; Hong Yao; Bo Tan
Journal:  Front Genet       Date:  2022-03-29       Impact factor: 4.599

7.  Hnrnpk maintains chondrocytes survival and function during growth plate development via regulating Hif1α-glycolysis axis.

Authors:  Yuyu Chen; Jinna Wu; Shun Zhang; Wenjie Gao; Zhiheng Liao; Taifeng Zhou; Yongyong Li; Deying Su; Hengyu Liu; Xiaoming Yang; Peiqiang Su; Caixia Xu
Journal:  Cell Death Dis       Date:  2022-09-20       Impact factor: 9.685

Review 8.  Kabuki Syndrome-Clinical Review with Molecular Aspects.

Authors:  Snir Boniel; Krystyna Szymańska; Robert Śmigiel; Krzysztof Szczałuba
Journal:  Genes (Basel)       Date:  2021-03-25       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.